AU2005305464A1 - Nonaqueous liquid parenteral Aceclofenac formulation - Google Patents
Nonaqueous liquid parenteral Aceclofenac formulation Download PDFInfo
- Publication number
- AU2005305464A1 AU2005305464A1 AU2005305464A AU2005305464A AU2005305464A1 AU 2005305464 A1 AU2005305464 A1 AU 2005305464A1 AU 2005305464 A AU2005305464 A AU 2005305464A AU 2005305464 A AU2005305464 A AU 2005305464A AU 2005305464 A1 AU2005305464 A1 AU 2005305464A1
- Authority
- AU
- Australia
- Prior art keywords
- aceclofenac
- formulation
- amendment
- polyethylene glycol
- propylene glycol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2332/DEL/2004 | 2004-11-22 | ||
| IN2332DE2004 | 2004-11-22 | ||
| PCT/IN2005/000339 WO2006054315A1 (en) | 2004-11-22 | 2005-10-19 | Nonaqueous liquid parenteral aceclofenac formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2005305464A1 true AU2005305464A1 (en) | 2006-05-26 |
Family
ID=35636806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2005305464A Abandoned AU2005305464A1 (en) | 2004-11-22 | 2005-10-19 | Nonaqueous liquid parenteral Aceclofenac formulation |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20090156670A1 (es) |
| EP (1) | EP1814517B1 (es) |
| JP (1) | JP2008520652A (es) |
| KR (1) | KR20070059154A (es) |
| CN (1) | CN101060832A (es) |
| AT (1) | ATE476962T1 (es) |
| AU (1) | AU2005305464A1 (es) |
| BR (1) | BRPI0516790A (es) |
| DE (1) | DE602005022913D1 (es) |
| ES (1) | ES2350452T3 (es) |
| MX (1) | MX2007006106A (es) |
| PL (1) | PL1814517T3 (es) |
| PT (1) | PT1814517E (es) |
| SI (1) | SI1814517T1 (es) |
| WO (1) | WO2006054315A1 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2222274B1 (en) * | 2007-11-29 | 2012-01-25 | AllTranz Inc. | Methods and compositons for enhancing the viability of microneedle pores |
| AR072777A1 (es) | 2008-03-26 | 2010-09-22 | Cephalon Inc | Formas solidas de clorhidrato de bendamustina |
| EP3158991B1 (en) | 2010-01-28 | 2021-03-17 | Eagle Pharmaceuticals, Inc. | Formulations of bendamustine |
| US8734852B2 (en) * | 2011-11-30 | 2014-05-27 | Manu Chaudhary | Parenteral controlled release formulations of NSAID's |
| US9034908B2 (en) | 2012-03-20 | 2015-05-19 | Eagle Pharmaceuticals, Inc. | Formulations of bendamustine |
| US8828979B2 (en) | 2012-03-27 | 2014-09-09 | Essential Ingredients, Inc. | Salicylic acid gel |
| US20140179740A1 (en) * | 2012-12-21 | 2014-06-26 | Mylan Inc. | Stable liquid remifentanil formulations |
| KR101598283B1 (ko) * | 2014-06-30 | 2016-02-29 | 이화여자대학교 산학협력단 | 안전성 및 효능이 증가된 월경통 완화 또는 치료용 복합제 조성물 |
| MX2019000312A (es) * | 2019-01-08 | 2019-10-09 | Federico Amezcua Amezcua | Composicion farmaceutica sinergica de aceclofenaco y betametasona para el tratamiento del dolor de afecciones reumaticas o dolor postquirurgico. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1231209A1 (en) * | 2000-12-19 | 2002-08-14 | Specialized Pharmaceutical Research Ltd. Co. | Prodrugs of non-steroidal anti-inflammatory and carboxylic acid containing compound |
| KR100425226B1 (ko) * | 2001-07-03 | 2004-03-30 | 주식회사 팜트리 | 아세클로페낙을 함유하는 경제적인 경구용 제제의 조성 및제법 |
| WO2004069788A1 (ja) * | 2003-02-07 | 2004-08-19 | Ono Pharmaceutical Co., Ltd. | カルボン酸化合物 |
-
2005
- 2005-10-19 BR BRPI0516790-6A patent/BRPI0516790A/pt not_active Application Discontinuation
- 2005-10-19 PT PT05808069T patent/PT1814517E/pt unknown
- 2005-10-19 AT AT05808069T patent/ATE476962T1/de active
- 2005-10-19 ES ES05808069T patent/ES2350452T3/es active Active
- 2005-10-19 JP JP2007542517A patent/JP2008520652A/ja active Pending
- 2005-10-19 WO PCT/IN2005/000339 patent/WO2006054315A1/en active Search and Examination
- 2005-10-19 EP EP05808069A patent/EP1814517B1/en active Active
- 2005-10-19 MX MX2007006106A patent/MX2007006106A/es unknown
- 2005-10-19 SI SI200531152T patent/SI1814517T1/sl unknown
- 2005-10-19 CN CNA200580039565XA patent/CN101060832A/zh active Pending
- 2005-10-19 PL PL05808069T patent/PL1814517T3/pl unknown
- 2005-10-19 KR KR1020077008756A patent/KR20070059154A/ko not_active Application Discontinuation
- 2005-10-19 US US11/719,906 patent/US20090156670A1/en not_active Abandoned
- 2005-10-19 DE DE602005022913T patent/DE602005022913D1/de active Active
- 2005-10-19 AU AU2005305464A patent/AU2005305464A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1814517A1 (en) | 2007-08-08 |
| KR20070059154A (ko) | 2007-06-11 |
| ATE476962T1 (de) | 2010-08-15 |
| JP2008520652A (ja) | 2008-06-19 |
| SI1814517T1 (sl) | 2010-12-31 |
| PL1814517T3 (pl) | 2011-02-28 |
| DE602005022913D1 (de) | 2010-09-23 |
| WO2006054315B1 (en) | 2006-08-17 |
| US20090156670A1 (en) | 2009-06-18 |
| EP1814517B1 (en) | 2010-08-11 |
| PT1814517E (pt) | 2010-11-03 |
| ES2350452T3 (es) | 2011-01-24 |
| MX2007006106A (es) | 2007-10-23 |
| BRPI0516790A (pt) | 2008-09-30 |
| WO2006054315A1 (en) | 2006-05-26 |
| CN101060832A (zh) | 2007-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1814517B1 (en) | Nonaqueous liquid parenteral aceclofenac formulation | |
| US6579895B2 (en) | Use of a celecoxib composition for fast pain relief | |
| AU2002256031B2 (en) | Reconstitutable parenteral composition containing a COX-2 inhibitor | |
| NZ528716A (en) | Stabilized oral pharmaceutical composition | |
| NZ526976A (en) | Pharmaceutical composition having reduced tendency for drug crystallization | |
| US20020049233A1 (en) | Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor | |
| AU2002256031A1 (en) | Reconstitutable parenteral composition containing a COX-2 inhibitor | |
| EP1446118B1 (en) | Oral dosage form of parecoxib | |
| US20040127537A1 (en) | Stable liquid parenteral parecoxib formulation | |
| CA2505106A1 (en) | Concentrated liquid valdecoxib composition | |
| US20040092566A1 (en) | Celecoxib prodrug | |
| ZA200307576B (en) | Orally deliverable pharmaceutical composition comprising an active compound having an aminosulfonyl group (Cox-2 inhibitor), a polyethylene glycol and a free-radical scavenging antioxidant. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1 | Application lapsed section 142(2)(a) - no request for examination in relevant period |